Search results for: niaid vaccine adjuvant

Award Notice

NEOANTIGEN VACCINE CLINICAL TRIALS Solicitation ID/Procurement Identifier: NCI-DCTD-20-0110 Ultimate Completion Date: Wed Sep 24 17:00:00 GMT 2025

CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: CONTINUED ON NEXT PAGE PAGE 5 OF 41 PAGES SPE7L7-23-T-6683 SECTION A GOVERNMENT IN THE PERFORMANCE OF ANY AWARD RESULTING FROM THIS SOLICITATION, IN ACCORDANCE WITH PARAGRAPH (d) OF THE CLAUSE AT FAR 52.204-24, REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT, OR IN ACCORDANCE WITH ITS EXISTING REPRESENTATION IN PARAGRAPH (c) OF THE PROVISION AT DFARS 252.204-7016, COVERED DEFENSE TELECOMMUNICATIONS EQUIPMENT OR SERVICES – REPRESENTATION. Caution Notice: Offerors are required to comply with domestic material restrictions. The Berry Amendment, the Buy American Act, and other domestic material restrictions may apply. Offerors are inst...

.- Data Science Tools for Accelerating Alcohol Research.NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID):- Co-delivery and Formulation of Adjuvants for HIV Vaccine Development.- Particle-based Co-delivery of HIV immunogens as Next-generation HIV Vaccines.- Sequence-based Assays to Quantify the Replication-Competent HIV Reservoir.- Small Molecule Targeting of HIV RNA.- Adjuvant Discovery for Vaccines against Infectious or Immune-mediated